The largest shareholders of Johnson & Johnson are major institutional asset management firms that hold shares on behalf of millions of mutual fund and ETF investors. Global financial institutions such as The Vanguard Group and BlackRock, Inc. consistently maintain the largest aggregate institutional equity stakes in the healthcare giant.